This question comes up constantly in peptide research communities and the short answer is: almost but not quite. The distinction matters if you’re doing research where precision is important, which it should be.
Here’s the full explanation.
What is Thymosin Beta-4?
Thymosin Beta-4 is a naturally occurring peptide found in virtually all human and animal cells. It’s a 43 amino acid peptide that plays a central role in actin sequestration, cell migration, and various processes related to tissue development and repair.
It was first isolated from thymus tissue, which is where the name comes from, but it’s now understood to be present throughout the body rather than being thymus-specific.
In research, the interest in Thymosin Beta-4 centers on its activity in cellular processes related to wound healing, angiogenesis, and inflammation modulation. It has a substantial body of published research behind it and is one of the better-characterized naturally occurring peptides in its class.
What is TB-500?
TB-500 is a synthetic peptide that corresponds to the active fragment of Thymosin Beta-4, specifically amino acids 17 to 23 of the full molecule: the sequence LKKTETQ.
This fragment is where the actin-binding activity of Thymosin Beta-4 is concentrated. Researchers identified this region as the functionally active portion of the larger molecule, and TB-500 was developed as a more practical research tool that captures that core activity in a shorter, more stable peptide.
So TB-500 is not Thymosin Beta-4. It is a synthetic fragment derived from the most biologically active portion of Thymosin Beta-4.
Why does the distinction matter?
For practical research purposes the distinction matters in a few specific ways.
The first is literature alignment. If your research is designed to replicate or build on existing published work, you need to know whether that work used the full Thymosin Beta-4 molecule or the TB-500 fragment. Using the wrong compound introduces a variable that affects comparability.
The second is activity profile. While TB-500 retains the actin-binding activity of the full molecule, Thymosin Beta-4 has additional biological activities beyond the fragment region. If your research requires the full range of Thymosin Beta-4 activity rather than specifically the actin-binding fragment activity, TB-500 may not be the appropriate tool.
The third is what your supplier is actually selling you. Most Canadian research peptide suppliers who list “TB-500” are selling the synthetic fragment, not the full Thymosin Beta-4 molecule. These are not interchangeable. Your COA should clearly identify which compound you received.
What most suppliers carry and why
Most Canadian research peptide suppliers carry TB-500 (the synthetic fragment) rather than the full Thymosin Beta-4 molecule. This is for practical reasons: the fragment is easier to synthesize, more stable, and the research demand for the specific actin-binding activity is well established.
If you specifically need the full Thymosin Beta-4 molecule for your research, confirm with your supplier which form they’re actually selling before ordering.
Sourcing TB-500 in Canada
Independent third-party testing. This is where the distinction becomes practically important. A COA for TB-500 should confirm the identity of the specific fragment (LKKTETQ), not just the purity. Mass spectrometry that confirms the molecular weight corresponding to the fragment is the gold standard. HPLC purity alone tells you the compound is predominantly one thing but doesn’t confirm it’s specifically the TB-500 fragment.
Correct compound identification on the COA. The documentation should be specific. “Thymosin Beta-4” and “TB-500” are different entries. Your COA should match exactly what you ordered.
Domestic sourcing. Standard reasons apply.
Where BioPerform fits in
BioPerform carries TB-500 third-party tested by Janoshik Analytical with batch-specific COAs on the product page before purchase. If you have questions about which form of the compound you’re receiving or want to review the documentation before ordering, the COA is on the product page and support@bioperform.ca is available for specific questions.
Orders placed before 2PM MST ship same-day from Alberta via Canada Post with tracking confirmation.
Payment is by Interac e-Transfer.
All BioPerform compounds are for research purposes only. Not intended for human consumption. For use by licensed researchers in controlled laboratory settings.